Adjuvant chemotherapy in new stage II pN0 non-small cell lung cancer: a new issue for a case-by-case decision making process
- PMID: 20421773
- DOI: 10.1097/JTO.0b013e3181d6bc50
Adjuvant chemotherapy in new stage II pN0 non-small cell lung cancer: a new issue for a case-by-case decision making process
Comment on
-
The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.J Thorac Oncol. 2007 Aug;2(8):706-14. doi: 10.1097/JTO.0b013e31812f3c1a. J Thorac Oncol. 2007. PMID: 17762336
Similar articles
-
Chemotherapy helps patients with advanced non-small cell carcinoma of the lung.N C Med J. 1996 Sep-Oct;57(5):281-6. N C Med J. 1996. PMID: 8854691 Review. No abstract available.
-
[New trends in adjuvant chemotherapy for non-small-cell lung cancer].Pneumologia. 2005 Apr-Jun;54(2):89-93. Pneumologia. 2005. PMID: 16536008 Review. Romanian. No abstract available.
-
[Does chemotherapy improve the results of postoperative radiotherapy in completely resected stage II and IIIA non-small-cell bronchial cancer?].Strahlenther Onkol. 2001 Apr;177(4):220-1. Strahlenther Onkol. 2001. PMID: 11370558 German. No abstract available.
-
[Chemotherapy for lung cancer].Nihon Rinsho. 2002 May;60 Suppl 5:309-16. Nihon Rinsho. 2002. PMID: 12101679 Review. Japanese. No abstract available.
-
[Controversies in the treatment of non-small cell lung cancer; adjuvant chemotherapy].Pneumologia. 2001 Apr-Jun;50(2):115-7. Pneumologia. 2001. PMID: 11584671 Romanian. No abstract available.
Cited by
-
A pooled exploratory analysis of the effect of tumor size and KRAS mutations on survival benefit from adjuvant platinum-based chemotherapy in node-negative non-small cell lung cancer.J Thorac Oncol. 2012 Jun;7(6):963-72. doi: 10.1097/JTO.0b013e31824fe9e6. J Thorac Oncol. 2012. PMID: 22588152 Free PMC article. Clinical Trial.